View Post

Top 5 Myths About Cancer Clinical Trials

In Clinical Trials by Barbara Jacoby

By: Jill Weberding From: medium.com Clinical trials are the only avenue that advances in medicine occur. Every approved drug or treatment must go through the clinical trial process. With the increasing pace of science and technology advances, there were 19 drugs with new approvals for cancer treatment in 2018 according to “CenterWatch” (n.d.). Despite the excitement of tapping into the …

View Post

Proton Therapy Coming to Kansas City with Opening of Provision CARES Proton Therapy Center

In In The News by Barbara Jacoby

Source: Provision Solutions From: PR Newswire Provision Healthcare announces the expansion of the Provision CARES Cancer Network with plans to develop the Provision CARES Cancer Center and Proton Therapy Center in Kansas City, KS. The center will be the first to open in Kansas, located in the Lenexa community of Kansas City to serve patients in the area and surrounding region …

View Post

Many Older Hospitalized Patients with Cancer Experience Malnutrition

In In The News by Barbara Jacoby

Source: Wiley Research News From: PR Newswire Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Many individuals with cancer experience malnutrition, which can …

View Post

Cancer accounts for more than one-quarter of new drug approvals, analysis finds

In Clinical Trials by Barbara Jacoby

By: Alaric DeArment From: medcitynews.com Overall, the report, from the Tufts Center for the Study of Drug Development, found that new cancer drug approvals since 2010 have increased by 4 percent since the 1980s. More than one-quarter of the drugs that have received Food and Drug Administration approval have been for cancers, according to a new analysis. The analysis, by …

View Post

Patent reform is needed to protect patients’ access to lifesaving drugs

In In The News by Barbara Jacoby

By: Lyrissa Lidsky From: statnews.com It’s no secret that the cost of prescription drugs is too high for many Americans to afford. Across the country, patients are struggling to access medicines they desperately need. In fact, we are charged, on average, significantly more than residents of other high-income countries for the same prescription drugs. These high prices are due in …

View Post

Where Cancer-killing T-cells Come From

In In The News by Barbara Jacoby

By: Shirley Dang From: parkerici.org New research published today in Nature Medicine by scientists from the Stanford University School of Medicine and the Parker Institute for Cancer Immunotherapy sheds new light on the origins of tumor-fighting immune cells following immunotherapy treatment with anti-PD-1 checkpoint inhibitors. Using single-cell RNA sequencing technology, the group discovered that T-cells homing in on cancer did …

View Post

I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

In Clinical Trials by Barbara Jacoby

Source: I-MAB Pharma From: prnewswire.com I-Mab Biopharma (“I-Mab”), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products Administration (NMPA) has approved its investigational new drug (IND) application for TJC4, a differentiated fully human CD47 monoclonal antibody internally developed for the treatment of advanced malignant …